BIODESIX, INC. Proceeds from Long-Term Debt Issued
BIODESIX, INC. (BDSX) reported Proceeds from Long-Term Debt Issued of $30.00 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-11.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2021-05-11
- BIODESIX, INC. proceeds from issuance of long-term debt for the quarter ending 2021-03-31 was $30.00M, a 368.09% increase year-over-year.
- BIODESIX, INC. proceeds from issuance of long-term debt for the quarter ending 2020-03-31 was $6.41M.
| Period end | Proceeds from Issuance of Long-term Debt 3 month |
|---|---|
| 2021-03-31 | $30.00M 10-Q · filed 2021-05-11 |
| 2020-03-31 | $6.41M 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |